Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Lenalidomide combined with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) (R2CHOP) in untreated diffuse large B-cell lymphoma (DLBCL) has shown promising activity, particularly in the activated B-cell–like (ABC) subtype. Eastern Cooperative Oncology Group (ECOG)-A...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Nowakowski, Grzegorz S., Hong, Fangxin, Scott, David W., Macon, William R., King, Rebecca L., Habermann, Thomas M., Wagner-Johnston, Nina, Casulo, Carla, Wade, James L., Nagargoje, Gauri G., Reynolds, C. M., Cohen, Jonathon B., Khan, Nadia, Amengual, Jennifer E., Richards, Kristy L., Little, R. F., Leonard, John P., Friedberg, Jonathan W., Kostakoglu, Lale, Kahl, Brad S., Witzig, Thomas E.
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2021
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078264/
https://ncbi.nlm.nih.gov/pubmed/33555941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.01375
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker